Philip Vickers PhD
Pharma and Biotech Executive. Board Member, Revance Therapeutics and AVROBIO
Dr Vickers has more than 30 years experience in the biotechnology and pharmaceutical industry. He has held senior leadership positions in Research and Development at Merck, Pfizer, Boehringer-Ingelheim, Resolvyx, and Shire. Most recently he served as the CEO and President of Northern Biologics and Faze Medicines. He is a member of the board of both Revance Therapeutics and AVRO Bio.
Dr Vickers holds a PhD in Biochemistry from the University of Toronto and a BSc in Applied Biochemistry from the University of Salford, United Kingdom. He was a Visiting Fellow at the National Cancer Institute in Bethesda, Maryland, prior to entering the pharmaceutical industry.